Warning: The NCBI web site requires JavaScript to function. more...

My NCBI Sign In

Result Filters

Clin Microbiol Rev. 2008 Jan;21(1):134-56.

Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.

Schroeder GN, Hilbi H.

Source

ETH Zürich, Institute of Microbiology, Wolfgang Pauli Strasse 10, HCI G405, 8093 Zürich, Switzerland.

Abstract

Shigella spp. are gram-negative pathogenic bacteria that evolved from harmless enterobacterial relatives and may cause devastating diarrhea upon ingestion. Research performed over the last 25 years revealed that a type III secretion system (T3SS) encoded on a large plasmid is a key virulence factor of Shigella flexneri. The T3SS determines the interactions of S. flexneri with intestinal cells by consecutively translocating two sets of effector proteins into the target cells. Thus, S. flexneri controls invasion into EC, intra- and intercellular spread, macrophage cell death, as well as host inflammatory responses. Some of the translocated effector proteins show novel biochemical activities by which they intercept host cell signal transduction pathways. An understanding of the molecular mechanisms underlying Shigella pathogenesis will foster the development of a safe and efficient vaccine, which, in parallel with improved hygiene, should curb infections by this widespread pathogen.

PMID:: 18202440; [PubMed - indexed for MEDLINE]
PMCID:: PMC2223840

Free PMC Article

Images from this publication.See all images (11) Free text

FIG. 2.

FIG. 4.

FIG. 6.

FIG. 8.

FIG. 10.

FIG. 1.

FIG. 3.

FIG. 5.

FIG. 7.

FIG. 9.

FIG. 11.

LinkOut - more resources

Full Text Sources

Supplemental Content

Icon for HighWire Press

Icon for PubMed Central

Save items

loading

Related citations in PubMed

Review Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors. [FEMS Microbiol Lett. 2005]
Review Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors.
Parsot C. FEMS Microbiol Lett. 2005 Nov 1; 252(1):11-8. Epub 2005 Sep 15.
OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence. [Infect Immun. 2006]
OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence.
Zurawski DV, Mitsuhata C, Mumy KL, McCormick BA, Maurelli AT. Infect Immun. 2006 Oct; 74(10):5964-76.
Small-molecule type III secretion system inhibitors block assembly of the Shigella type III secreton. [J Bacteriol. 2009]
Small-molecule type III secretion system inhibitors block assembly of the Shigella type III secreton.
Veenendaal AK, Sundin C, Blocker AJ. J Bacteriol. 2009 Jan; 191(2):563-70. Epub 2008 Nov 7.
The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections. [Infect Immun. 2008]
The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.
Zurawski DV, Mumy KL, Badea L, Prentice JA, Hartland EL, McCormick BA, Maurelli AT. Infect Immun. 2008 Jan; 76(1):369-79. Epub 2007 Nov 5.
Review Shigella type III secretion effectors: how, where, when, for what purposes? [Curr Opin Microbiol. 2009]
Review Shigella type III secretion effectors: how, where, when, for what purposes?
Parsot C. Curr Opin Microbiol. 2009 Feb; 12(1):110-6. Epub 2009 Jan 20.

See reviews... See all...

Cited by 32 PubMed Central articles

Structure of a type III secretion needle at 7-Å resolution provides insights into its assembly and signaling mechanisms. [Proc Natl Acad Sci U S A. 2012]
Structure of a type III secretion needle at 7-Å resolution provides insights into its assembly and signaling mechanisms.
Fujii T, Cheung M, Blanco A, Kato T, Blocker AJ, Namba K. Proc Natl Acad Sci U S A. 2012 Mar 20; 109(12):4461-6. Epub 2012 Mar 2.
Phenotypic pattern-based assay for dynamically monitoring host cellular responses to Salmonella infections. [PLoS One. 2011]
Phenotypic pattern-based assay for dynamically monitoring host cellular responses to Salmonella infections.
Mou X, Wan S, Li Y, Zhang S, Sun M, Liu F, Fu H, Zhang X, Liu H, Cao Q, et al. PLoS One. 2011; 6(11):e26544. Epub 2011 Nov 3.
Contribution of the lipopolysaccharide to resistance of Shigella flexneri 2a to extreme acidity. [PLoS One. 2011]
Contribution of the lipopolysaccharide to resistance of Shigella flexneri 2a to extreme acidity.
Martinić M, Hoare A, Contreras I, Alvarez SA. PLoS One. 2011; 6(10):e25557. Epub 2011 Oct 3.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioSystems
Pathways and biological systems (BioSystems) that cite the current articles. Citations are from the BioSystems source databases (KEGG and BioCyc).
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasi...
Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.
Clin Microbiol Rev. 2008 Jan ;21(1):134-56.

PubMed
Individualized prediction of colon cancer recurrence using a nomogram.
Individualized prediction of colon cancer recurrence using a nomogram.
J Clin Oncol. 2008 Jan 20 ;26(3):380-5.

PubMed
Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (...
Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (AP23573; MK-8669) administered intravenously daily for 5 days every 2 weeks to patients with advanced malignancies.
J Clin Oncol. 2008 Jan 20 ;26(3):361-7.

PubMed
A gain-of-function suppressor screen for genes involved in dorsal-ventral bounda...
A gain-of-function suppressor screen for genes involved in dorsal-ventral boundary formation in the Drosophila wing.
Genetics. 2008 Jan ;178(1):307-23.

PubMed
Spatial and temporal control of gene expression in Drosophila using the inducibl...
Spatial and temporal control of gene expression in Drosophila using the inducible GeneSwitch GAL4 system. I. Screen for larval nervous system drivers.
Genetics. 2008 Jan ;178(1):215-34.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Literature > PubMed

Write to the Help Desk